Correlation Between Kymera Therapeutics and Mirati Ther
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Mirati Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Mirati Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Mirati Ther, you can compare the effects of market volatilities on Kymera Therapeutics and Mirati Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Mirati Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Mirati Ther.
Diversification Opportunities for Kymera Therapeutics and Mirati Ther
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Kymera and Mirati is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Mirati Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirati Ther and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Mirati Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirati Ther has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Mirati Ther go up and down completely randomly.
Pair Corralation between Kymera Therapeutics and Mirati Ther
Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 1.49 times more return on investment than Mirati Ther. However, Kymera Therapeutics is 1.49 times more volatile than Mirati Ther. It trades about 0.07 of its potential returns per unit of risk. Mirati Ther is currently generating about -0.21 per unit of risk. If you would invest 2,275 in Kymera Therapeutics on September 1, 2024 and sell it today you would earn a total of 2,410 from holding Kymera Therapeutics or generate 105.93% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 8.33% |
Values | Daily Returns |
Kymera Therapeutics vs. Mirati Ther
Performance |
Timeline |
Kymera Therapeutics |
Mirati Ther |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kymera Therapeutics and Mirati Ther Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kymera Therapeutics and Mirati Ther
The main advantage of trading using opposite Kymera Therapeutics and Mirati Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Mirati Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirati Ther will offset losses from the drop in Mirati Ther's long position.Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Mirati Ther vs. Sarepta Therapeutics | Mirati Ther vs. Krystal Biotech | Mirati Ther vs. Day One Biopharmaceuticals | Mirati Ther vs. Amylyx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |